Document is current

Any future updates will be listed below

Risk of drug eruption associated with the use of tetracyclines, macrolides, and fluoroquinolones: real-world evidence from a pharmacovigilance study utilizing the FDA adverse event reporting system

Crossref DOI link: https://doi.org/10.1007/s44446-025-00058-8

Published Online: 2026-01-13

Published Print: 2026-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark